RGEN logo

RGEN
Repligen Corp.

1,555
Mkt Cap
$6.43B
Volume
1,279.00
52W High
$175.77
52W Low
$109.50
PE Ratio
131.95
RGEN Fundamentals
Price
$114.99
Prev Close
$114.06
Open
$115.60
50D MA
$123.89
Beta
1.47
Avg. Volume
922,458.40
EPS (Annual)
$0.8644
P/B
3.05
Rev/Employee
$369,128.00
$9,190.41
Loading...
Loading...
News
all
press releases
Repligen (NASDAQ:RGEN) Reaches New 1-Year Low - Should You Sell?
Repligen (NASDAQ:RGEN) Reaches New 1-Year Low - Here's What Happened...
MarketBeat·5h ago
News Placeholder
More News
News Placeholder
Repligen (NASDAQ:RGEN) Stock Price Down 10.3% - Time to Sell?
Repligen (NASDAQ:RGEN) Trading Down 10.3% - Should You Sell...
MarketBeat·21h ago
News Placeholder
M&T Bank Corp Purchases New Holdings in Repligen Corporation $RGEN
M&T Bank Corp purchased a new stake in shares of Repligen Corporation (NASDAQ:RGEN - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange...
MarketBeat·1d ago
News Placeholder
Repligen (NASDAQ:RGEN) Earns Buy Rating from Analysts at Roth Mkm
Roth Mkm initiated coverage on shares of Repligen in a research note on Friday. They issued a "buy" rating and a $160.00 price target for the company...
MarketBeat·7d ago
News Placeholder
Short Interest in Repligen Corporation (NASDAQ:RGEN) Rises By 28.0%
Repligen Corporation (NASDAQ:RGEN - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totaling 5,556,333 shares, an...
MarketBeat·8d ago
News Placeholder
Massachusetts Financial Services Co. MA Makes New $199.18 Million Investment in Repligen Corporation $RGEN
Massachusetts Financial Services Co. MA acquired a new position in Repligen Corporation (NASDAQ:RGEN - Free Report) in the fourth quarter, according to the company in its most recent filing with the...
MarketBeat·11d ago
News Placeholder
Repligen Corporation (NASDAQ:RGEN) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Repligen Corporation (NASDAQ:RGEN - Get Free Report) have received an average recommendation of "Moderate Buy" from the fourteen brokerages that are covering the company, Marketbeat.com...
MarketBeat·17d ago
News Placeholder
Are Options Traders Betting on a Big Move in Repligen Stock?
Investors need to pay close attention to RGEN stock based on the movements in the options market lately.
Zacks·23d ago
News Placeholder
Riverbridge Partners LLC Sells 30,070 Shares of Repligen Corporation $RGEN
Riverbridge Partners LLC reduced its position in Repligen Corporation (NASDAQ:RGEN - Free Report) by 8.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 313,365 shares of the biotechn...
MarketBeat·28d ago
News Placeholder
Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound?
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·29d ago
<
1
2
...
>

Latest RGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.